These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 19602906

  • 1. Genetic polymorphisms of hypoxia-inducible factor-1 alpha and cardiovascular disease in hemodialysis patients.
    Zheng ZL, Hwang YH, Kim SK, Kim S, Son MJ, Ro H, Sung SA, Lee HH, Chung WK, Joo KW, Yang J.
    Nephron Clin Pract; 2009; 113(2):c104-11. PubMed ID: 19602906
    [Abstract] [Full Text] [Related]

  • 2. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
    Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A.
    Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
    [Abstract] [Full Text] [Related]

  • 3. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer.
    Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E, Ekmekci A.
    Arch Med Res; 2008 Apr; 39(3):338-45. PubMed ID: 18279708
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
    Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B, Gamallo C.
    Ann Surg Oncol; 2009 Aug; 16(8):2351-8. PubMed ID: 19449077
    [Abstract] [Full Text] [Related]

  • 5. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
    Knechtel G, Szkandera J, Stotz M, Hofmann G, Langsenlehner U, Krippl P, Samonigg H, Renner W, Langner C, Dehchamani D, Gerger A.
    Mol Carcinog; 2010 Sep; 49(9):805-9. PubMed ID: 20572162
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease.
    Hlatky MA, Quertermous T, Boothroyd DB, Priest JR, Glassford AJ, Myers RM, Fortmann SP, Iribarren C, Tabor HK, Assimes TL, Tibshirani RJ, Go AS.
    Am Heart J; 2007 Dec; 154(6):1035-42. PubMed ID: 18035072
    [Abstract] [Full Text] [Related]

  • 7. Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer.
    Konac E, Dogan I, Onen HI, Yurdakul AS, Ozturk C, Varol A, Ekmecki A.
    Exp Biol Med (Maywood); 2009 Sep; 234(9):1109-16. PubMed ID: 19546348
    [Abstract] [Full Text] [Related]

  • 8. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype.
    Ollerenshaw M, Page T, Hammonds J, Demaine A.
    Cancer Genet Cytogenet; 2004 Sep; 153(2):122-6. PubMed ID: 15350301
    [Abstract] [Full Text] [Related]

  • 9. Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women.
    Lee JY, Choi JY, Lee KM, Park SK, Han SH, Noh DY, Ahn SH, Kim DH, Hong YC, Ha E, Yoo KY, Ambrosone CB, Kang D.
    Clin Chim Acta; 2008 Mar; 389(1-2):167-70. PubMed ID: 18160046
    [Abstract] [Full Text] [Related]

  • 10. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients.
    Fransén K, Fenech M, Fredrikson M, Dabrosin C, Söderkvist P.
    Mol Carcinog; 2006 Nov; 45(11):833-40. PubMed ID: 16865676
    [Abstract] [Full Text] [Related]

  • 11. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M, Ksiazek P, Zukowski P, Benedyk-Lorens E, Orlowska-Kowalik G.
    Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
    [Abstract] [Full Text] [Related]

  • 12. Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
    Szkandera J, Knechtel G, Stotz M, Hofmann G, Langsenlehner U, Krippl P, Langsenlehner T, Dehchamani D, Samonigg H, Renner W, Gerger A.
    Anticancer Res; 2010 Jun; 30(6):2393-7. PubMed ID: 20651398
    [Abstract] [Full Text] [Related]

  • 13. Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients.
    Buraczynska M, Ksiazek P, Wacinski P, Zukowski P, Dragan M, Bednarek-Skublewska A.
    Hum Immunol; 2010 Sep; 71(9):878-82. PubMed ID: 20538029
    [Abstract] [Full Text] [Related]

  • 14. Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors.
    Wiedmann S, Neureuther K, Stark K, Reinhard W, Kallmünzer B, Baessler A, Fischer M, Linsel-Nitschke P, Erdmann J, Schunkert H, Hengstenberg C.
    Obesity (Silver Spring); 2009 Jul; 17(7):1390-5. PubMed ID: 19197259
    [Abstract] [Full Text] [Related]

  • 15. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males.
    Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K.
    J Am Soc Nephrol; 2006 Mar; 17(3):823-30. PubMed ID: 16421229
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.